Literature DB >> 24070927

Vascular protection in people with diabetes.

James A Stone, David Fitchett, Steven Grover, Richard Lewanczuk, Peter Lin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24070927     DOI: 10.1016/j.jcjd.2013.01.030

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN: 1499-2671            Impact factor:   4.190


× No keyword cloud information.
  5 in total

1.  Sex and gender considerations in Canadian clinical practice guidelines: a systematic review.

Authors:  Cara Tannenbaum; Barbara Clow; Margaret Haworth-Brockman; Patrice Voss
Journal:  CMAJ Open       Date:  2017-02-10

2.  Chronic kidney disease in type 2 diabetes: Does an abnormal urine albumin-to-creatinine ratio need to be retested?

Authors:  Divya Garg; Christopher Naugler; Vishal Bhella; Fahmida Yeasmin
Journal:  Can Fam Physician       Date:  2018-10       Impact factor: 3.275

Review 3.  Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach.

Authors:  Sagar Dugani; Jeffrey M Ames; JoAnn E Manson; Samia Mora
Journal:  Curr Atheroscler Rep       Date:  2018-02-21       Impact factor: 5.113

4.  Connexin-Based Therapeutics and Tissue Engineering Approaches to the Amelioration of Chronic Pancreatitis and Type I Diabetes: Construction and Characterization of a Novel Prevascularized Bioartificial Pancreas.

Authors:  J Matthew Rhett; Hongjun Wang; Heather Bainbridge; Lili Song; Michael J Yost
Journal:  J Diabetes Res       Date:  2015-12-14       Impact factor: 4.011

5.  Impact of the diabetes Canada guideline dissemination strategy on dispensed vascular protective medications for older patients in Ontario, Canada: a linked EMR and administrative data study.

Authors:  Michelle Greiver; Sumeet Kalia; Rahim Moineddin; Simon Chen; Raquel Duchen; Alanna Rigobon
Journal:  BMC Health Serv Res       Date:  2020-05-01       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.